TY - JOUR
AU - Cortese, Samuele
AU - Asherson, Philip
AU - Sonuga-Barke, Edmund
AU - Banaschewski, Tobias
AU - Brandeis, Daniel
AU - Buitelaar, Jan
AU - Coghill, David
AU - Daley, David
AU - Danckaerts, Marina
AU - Dittmann, Ralf W.
AU - Doepfner, Manfred
AU - Ferrin, Maite
AU - Hollis, Chris
AU - Holtmann, Martin
AU - Konofal, Eric
AU - Lecendreux, Michel
AU - Santosh, Paramala
AU - Rothenberger, Aribert
AU - Soutullo, César
AU - Steinhausen, Hans-Christoph
AU - Taylor, Eric
AU - Van der Oord, Saskia
AU - Wong, Ian
AU - Zuddas, Alessandro
AU - Simonoff, Emily
PY - 2020
DA - June
TI - ADHD management during the COVID-19 pandemic: guidance from the European ADHD Guidelines Group
JO - The Lancet Child & Adolescent Health
EP - 414
VL - 4
IS - 6
DO - https://doi.org/10.1016/S2352-4642(20)30110-3
AB - The coronavirus disease 2019 (COVID-19) pandemic is creating unprecedented challenges at every level of society. Individuals with neurodevelopmental disorders, such as attention-deficit hyperactivity disorder (ADHD), are particularly vulnerable to the distress caused by the pandemic and physical distancing measures, and they might display increased behavioural problems. The crisis also poses several important questions for clinicians on how best to deliver care within the new restrictions. Therefore, the European ADHD Guidelines Group (EAGG) has developed guidance on the assessment and management of ADHD during the COVID-19 virus pandemic.
PB - Elsevier
UR - https://discovery.dundee.ac.uk/en/publications/2d8647e4-f141-4310-8cb5-ccdec343a1b1
KW - Coronavirus (COVID-19)
ER